Logotype for Senzime

Senzime (SEZI) investor relations material

Senzime European Growth Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Senzime
European Growth Conference 2025 summary11 Sep, 2025

Key insights from presentations

  • Introduced a neuromuscular monitoring system, TetraGraph, enabling safer anesthesia and reducing postoperative complications through real-time, quantitative monitoring.

  • TetraGraph uses electromyography for high accuracy (99.7%) and has been adopted in over 4,000 operating rooms, monitoring 750,000+ patients globally.

  • Recent industry guidelines now recommend quantitative monitoring for all patients receiving paralytic agents, driving rapid adoption and business growth.

  • The company’s technology reduces drug costs by up to 70% and is especially valuable in robotic surgeries requiring deep neuromuscular blockade.

  • Partnerships with major firms like Fukuda Denshi and Philips expand integration and market reach, with strong traction in the U.S., Europe, and Asia.

Announcements and business performance

  • Achieved 90% revenue growth in the first half of the year, with sensors as the main growth driver and the U.S. accounting for 70% of business.

  • Installed base and recurring revenue from disposable sensors are growing at triple-digit rates, with over 700 new units delivered in Q2.

  • Targeting profitability by 2027 and cash flow positivity in 2026, with a focus on keeping operating expenses fixed while scaling.

  • Market opportunity exceeds $2 billion, with recurring revenue potential of $5,000 per monitor annually and significant room for further hospital conversions.

  • Backed by strong investors, including the Crawford family and major Swedish pension funds, supporting long-term global expansion.

Industry analysis and competitive positioning

  • Electromyography is emerging as the new gold standard in neuromuscular monitoring, replacing subjective and less accurate legacy methods.

  • The company leads in published studies, clinical validation, and IP portfolio (107 patents), with broad system connectivity to major hospital IT platforms.

  • Competitive edge comes from scientific leadership, commercial team expertise, product simplicity, and sustainability credentials.

  • Win rate is high in competitive evaluations, with most deals won in active markets and strong customer support throughout the adoption process.

  • Anticipates further growth from new pediatric guidelines and ongoing expansion in Asia and other global markets.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Senzime earnings date

Logotype for Senzime
Q3 202529 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Senzime earnings date

Logotype for Senzime
Q3 202529 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Senzime AB is a medical technology company specializing in patient monitoring systems designed to enhance safety and efficiency in healthcare. The company develops and manufactures solutions for monitoring neuromuscular function and other critical physiological parameters during and after surgery. Senzime’s products aim to reduce complications, improve outcomes, and support personalized care in operating rooms and recovery units. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage